AR and pachyonychia congenita: In support of previous findings, we show Aurora A expression is elevated in PC, and further increased in CRPC (Fig. 1c), and is a positive regulator of FL-AR function (Supplementary Figure S1) suggesting a role in therapy-resistance and disease progression.